227 related articles for article (PubMed ID: 26043337)
41. Prevalence and clinical relevance of interview-assessed psychosis-risk symptoms in the young adult community.
Schultze-Lutter F; Michel C; Ruhrmann S; Schimmelmann BG
Psychol Med; 2018 May; 48(7):1167-1178. PubMed ID: 28889802
[TBL] [Abstract][Full Text] [Related]
42. Two-Year Clinical and Functional Outcomes of an Asian Cohort at Ultra-High Risk of Psychosis.
Chan CT; Abdin E; Subramaniam M; Tay SA; Lim LK; Verma S
Front Psychiatry; 2018; 9():758. PubMed ID: 30761027
[No Abstract] [Full Text] [Related]
43. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
[TBL] [Abstract][Full Text] [Related]
44. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
[TBL] [Abstract][Full Text] [Related]
45. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
[TBL] [Abstract][Full Text] [Related]
46. Prevalence and Clinical Significance of Symptoms at Ultra High Risk for Psychosis in Children and Adolescents with Obsessive⁻Compulsive Disorder: Is There an Association with Global, Role, and Social Functioning?
Averna R; Pontillo M; Demaria F; Armando M; Santonastaso O; Pucciarini ML; Tata MC; Mancini F; Vicari S
Brain Sci; 2018 Sep; 8(10):. PubMed ID: 30274329
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of non-psychotic disorders in ultra-high risk individuals and transition to psychosis: A systematic review.
Albert U; Tomassi S; Maina G; Tosato S
Psychiatry Res; 2018 Dec; 270():1-12. PubMed ID: 30243126
[TBL] [Abstract][Full Text] [Related]
48. Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment.
Salazar de Pablo G; Catalan A; Fusar-Poli P
JAMA Psychiatry; 2020 Mar; 77(3):311-320. PubMed ID: 31746950
[TBL] [Abstract][Full Text] [Related]
49. Clinical profile and conversion rate to full psychosis in a prospective cohort study of youth affected by autism spectrum disorder and attenuated psychosis syndrome: A preliminary report.
Riccioni A; Siracusano M; Vasta M; Ribolsi M; Nastro FF; Gialloreti LE; Di Lorenzo G; Mazzone L
Front Psychiatry; 2022; 13():950888. PubMed ID: 36213900
[TBL] [Abstract][Full Text] [Related]
50. Adolescents and adults at clinical high-risk for psychosis: age-related differences in attenuated positive symptoms syndrome prevalence and entanglement with basic symptoms.
Gerstenberg M; Theodoridou A; Traber-Walker N; Franscini M; Wotruba D; Metzler S; Müller M; Dvorsky D; Correll CU; Walitza S; Rössler W; Heekeren K
Psychol Med; 2016 Apr; 46(5):1069-78. PubMed ID: 26671170
[TBL] [Abstract][Full Text] [Related]
51. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
52. [Early detection of psychotic disorders].
Schäfer MR; Klier CM; Papageorgiou K; Friedrich MH; Amminger GP
Neuropsychiatr; 2007; 21(1):37-44. PubMed ID: 17555006
[TBL] [Abstract][Full Text] [Related]
53. Differences Between Self-Reported Psychotic Experiences, Clinically Relevant Psychotic Experiences, and Attenuated Psychotic Symptoms in the General Population.
Moriyama TS; van Os J; Gadelha A; Pan PM; Salum GA; Manfro GG; Mari JJ; Miguel EC; Rohde LA; Polanczyk GV; McGuire P; Bressan RA; Drukker M
Front Psychiatry; 2019; 10():782. PubMed ID: 31736802
[No Abstract] [Full Text] [Related]
54. Psychopathological characteristics in ultra-high risk for psychosis with and without comorbid ADHD.
Ribolsi M; Prosperi Porta D; Sacco R; Di Lorenzo G; Fiori Nastro F; Albergo G; Di Lazzaro V; Costa A
Early Interv Psychiatry; 2024 May; ():. PubMed ID: 38690753
[TBL] [Abstract][Full Text] [Related]
55. Basic symptoms in the general population and in psychotic and non-psychotic psychiatric adolescents.
Meng H; Schimmelmann BG; Koch E; Bailey B; Parzer P; Günter M; Mohler B; Kunz N; Schulte-Markwort M; Felder W; Zollinger R; Bürgin D; Resch F
Schizophr Res; 2009 Jun; 111(1-3):32-8. PubMed ID: 19321309
[TBL] [Abstract][Full Text] [Related]
56. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people.
Yung AR; Stanford C; Cosgrave E; Killackey E; Phillips L; Nelson B; McGorry PD
Schizophr Res; 2006 May; 84(1):57-66. PubMed ID: 16630707
[TBL] [Abstract][Full Text] [Related]
57. Borderline personality features and development of psychosis in an 'ultra high risk' (UHR) population: a case control study.
Thompson A; Nelson B; Bechdolf A; Chanen AM; Domingues I; McDougall E; Yung AR
Early Interv Psychiatry; 2012 Aug; 6(3):247-55. PubMed ID: 22672502
[TBL] [Abstract][Full Text] [Related]
58. Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals.
Amminger GP; Leicester S; Yung AR; Phillips LJ; Berger GE; Francey SM; Yuen HP; McGorry PD
Schizophr Res; 2006 May; 84(1):67-76. PubMed ID: 16677803
[TBL] [Abstract][Full Text] [Related]
59. Suicidal ideation in individuals at ultra-high risk for psychosis and its association with suspiciousness independent of depression.
Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
Early Interv Psychiatry; 2019 Jun; 13(3):539-545. PubMed ID: 29164799
[TBL] [Abstract][Full Text] [Related]
60. Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis.
Hartmann JA; McGorry PD; Schmidt SJ; Amminger GP; Yuen HP; Markulev C; Berger GE; Chen EYH; de Haan L; Hickie IB; Lavoie S; McHugh MJ; Mossaheb N; Nieman DH; Nordentoft M; Riecher-Rössler A; Schäfer MR; Schlögelhofer M; Smesny S; Thompson A; Verma SK; Yung AR; Nelson B
Psychother Psychosom; 2017; 86(5):292-299. PubMed ID: 28903120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
